Exhaustive screening of the 21-hydroxylase gene in a population of hyperandrogenic women
The DOI matches its Crossref record; 25 of the 25 references it cites were found in a registry or an index.
Abstract
21-hydroxylase (21-OH) deficiency accounts for the vast majority of nonclassic (NC) forms of congenital adrenal hyperplasia (CAH), and is associated with symptoms detectable either in childhood (precocious puberty) or sometimes only later in adulthood (hirsutism, acne, amenorrhea). While the severe forms of the disease responsible for salt wasting or simple virilization have been extensively studied, the NC 21-OH deficiency is less well characterized, especially in adults. We studied the 21-OH gene (CYP21) in a population of 69 unrelated hyperandrogenic subjects suspected to be homozygous or heterozygous for NC 21-OH deficiency, based on basal and adrenocorticotrophin (ACTH)-stimulated plasma 17-hydroxyprogesterone (17-OHP, 17-OHPSI) and 21-desoxycortisol (21-DOF, 21-DOFSI) levels. To identify all mutations involved, determination of the whole gene sequence, including exons, exon-intron junctions, and promoter region, was performed, followed by a study of large rearrangements and identification of compound heterozygotes. Alterations were identified in at least one allele of 55 hyperandrogenic subjects. Two NC alterations, Val282Leu and Pro454Ser, were detected in 68% and 7% of the affected alleles, respectively, whereas mutations involved in severe forms were identified in 21% of them. These results document the utility of a molecular diagnosis in hyperandrogenic women suspected of being either heterozygous or homozygous for NC 21-OH deficiency and clearly indicate the importance of genetic counseling in such a population.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“A point mutation in exon 7 (p.Val281Leu) that preserves 20% to 50% of enzyme function (38) accounts for most NCCAH alleles (31,39,40).”
From Congenital Adrenal Hyperplasia Due to Steroid 21-Hydroxylase Deficiency: An Endocrine Society* Clinical Practice Guideline (2018) · cites this paper as [39]
Citations
Cites
Structure of human steroid 21-hydroxylase genes.
White, P. C., New, M. I., & Dupont, B. (1986) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.83.14.5111 · Cited by 569
Higashi, Y., Yoshioka, H., Yamane, M., Gotoh, O., & Fujii-Kuriyama, Y. (1986) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.83.9.2841 · Cited by 555 · cited 1×
“These alterations affect the secondary structure of the 21-OH enzyme, which presents a residual activity of 20% to 60% in vitro (Tusie-Luna et al. 1990, 1991; Helmberg et al. 1992; Owerbach et al. 1992; Nikoshkov et al. 1997).”
BackgroundHigh frequency of nonclassical steroid 21-hydroxylase deficiency
SPEISER, P. W., DUPONT, B. O., RUBINSTEIN, P., PIAZZA, A., KASTELAN, A., & NEW, M. I. (1986) · Obstetrical & Gynecological Survey · doi:10.1097/00006254-198604000-00017 · Cited by 523
Wedell, A. (1994) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.78.5.1145 · Cited by 370
Steroid 21-hydroxylase deficiency: genotype may not predict phenotype
Wilson, R. C. (1995) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.80.8.2322 · Cited by 324
Tusie-Luna, M. T., Traktman, P., & White, P. C. (1990) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)45304-x · Cited by 254
Speiser, P. W., New, M. I., & White, P. C. (1988) · New England Journal of Medicine · doi:10.1056/nejm198807073190104 · Cited by 205
Tusie-Luna, M.-T., Speiser, P. W., Dumic, M., New, M. I., & White, P. C. (1991) · Molecular Endocrinology · doi:10.1210/mend-5-5-685 · Cited by 183 · cited 1×
“These alterations affect the secondary structure of the 21-OH enzyme, which presents a residual activity of 20% to 60% in vitro ( Tusie-Luna et al. 1990, 1991; Helmberg et al. 1992; Owerbach et al. 1992; Nikoshkov et al. 1997).”
Background(1991) · Europe PMC (PubMed Central) · Cited by 164
Wedell, A., Ritzén, E. M., Haglund-Stengler, B., & Luthman, H. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.15.7232 · Cited by 150 · cited 3×
“... 15 s 273 caggccagccgctcagcc gggaaggagccttttgcttg Exon 8 59 30 s 251 ctgctggggcaggactcca cgggctttcctcactcatcc Exon 9 59 30 s 178 aggtcctggccagcctctaa caccacattttcacggcagg Exon 10 60 30 s 389 tgccgtgaaaatgtggtgga gcaataaaggagaaactgaggt a From Wedell et al. (1992) b From Day et al. (1995) c Sequence determination of…”
BackgroundMethodInfluential
Cited by
Speiser, P. W., Azziz, R., Baskin, L. S., Ghizzoni, L., Hensle, T. W., Merke, D. P., Meyer-Bahlburg, H. F. L., Miller, W. L., Montori, V. M., Oberfield, S. E., et al. (2010) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2009-2631 · Cited by 1,468
Congenital adrenal hyperplasia due to 21-hydroxylase deficiency*
White, P. C., & Speiser, P. W. (2000) · Endocrine Reviews · doi:10.1210/edrv.21.3.0398 · Cited by 1,432
“Nevertheless, it appears that at least 50% of women clinically ascertained to have nonclassic CAH are compound heterozygotes for a classic and a nonclassic mutation (209, 210, 334).”
BackgroundSpeiser, P. W., Arlt, W., Auchus, R. J., Baskin, L. S., Conway, G. S., Merke, D. P., Meyer-Bahlburg, H. F. L., Miller, W. L., Murad, M. H., Oberfield, S. E., et al. (2018) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2018-01865 · Cited by 1,234
PW, S., W, A., RJ, A., LS, B., GS, C., DP, M., HFL, M.-B., WL, M., MH, M., SE, O., et al. (2019) · Yearbook of Paediatric Endocrinology · doi:10.1530/ey.16.8.5 · Cited by 300
Kuismanen, S. A., Holmberg, M. T., Salovaara, R., de la Chapelle, A., & Peltomäki, P. (2000) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)65048-1 · Cited by 288
Metadata
- Authors
- Blanché, H., Vexiau, P., Clauin, S., Le Gall, I., Fiet, J., Mornet, E., Dausset, J., & Bellanné-Chantelott, C.
- Affiliations
- Fondation Jean Dausset-CEPH (FR)
- Hôpital Saint-Louis (FR)
- ORCID
- Blanché, Hélène
- Venue
- Human Genetics
- Published
- 1997-10
- Volume
- 101
- Issue
- 1
- Pages
- 56-60
- ISSN
- 0018-7348 (ISSN-L)
- 0340-6717
- 1432-1203
- OpenAlex
- W2031439430
- Cited by
- 85
- References
- 25
- Citations by year
- 2024: 1 · 2023: 1 · 2022: 4 · 2021: 3 · 2020: 2 · 2019: 2 · 2018: 1 · 2016: 1 · 2014: 1 · 2013: 2
- FWCI
- 1.42
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springernature.com/gp/researchers/text-and-data-mining (tdm)
- www.springernature.com/gp/researchers/text-and-data-mining (vor)
- www.springer.com/tdm (tdm)
- www.springer.com/tdm (vor)
- Locations
- Human Genetics (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Sexual Differentiation and Disorders
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adrenal Hormones and Disorders
- Health Sciences › Medicine › Reproductive Medicine › Ovarian function and disorders
- Keywords
- 21-hydroxylase deficiency, non-classical congenital adrenal hyperplasia, CYP21, hyperandrogenism, 17-hydroxyprogesterone, compound heterozygosity, molecular diagnosis, genetic counseling
- MeSH terms
- Adolescent, Adrenal Hyperplasia, Congenital, Adrenocorticotropic Hormone, Adult, Alleles, Base Sequence, Child, Cortodoxone, Female, Genetic Counseling, Genetic Testing, Genotype, Heterozygote, Hirsutism, Homozygote, Humans, Middle Aged, Mutation, Phenotype, Steroid 21-Hydroxylase, Polymerase Chain Reaction, Hyperandrogenism, DNA Primers, 17-alpha-Hydroxyprogesterone
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Exhaustive screening of the 21-hydroxylase gene in a population of hyperandrogenic women. https://app.cochat.ai/papers/10.1007/s004390050586
- The paper
- Blanché, H., Vexiau, P., Clauin, S., Le Gall, I., Fiet, J., Mornet, E., Dausset, J., & Bellanné-Chantelott, C. (1997). Exhaustive screening of the 21-hydroxylase gene in a population of hyperandrogenic women. Human Genetics. https://doi.org/10.1007/s004390050586
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.